Clotting disorders, Bleeding disorders, Platelet disorders
Heparin-induced thrombocytopenia, Immune thrombocytopenia, Thrombosis, Anticoagulation, Platelet disorders
Cuker A, Rux AH, Hinds JL, Dela Cruz M, Yarovoi SV, Brown IAM, Yang W, Konkle BA, Arepally GM, Watson SP, Cines DB, Sachais BS: Novel diagnostic assays for heparin-induced thrombocytopenia. Blood 121: 3727-3732, 2013.
Cuker A, Cines DB: Protamine-induced thrombocytopenia? Blood 121: 2818-2819, 2013
Siegal D, Cuker A: Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis 35: 391-398, 2013
Sood S, Cuker A, Wang C, Metjian A, Chiang E, Soucie J, Konkle B: Similarity in Joint Function Limitation in Type 3 Von Willebrand Disease and Moderate Haemophilia A. Haemophilia 19(4): 595-601, 2013
Tanhehco YC, Cuker A, Rudnick M, Sachais BS: Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis. Thromb Res 131: 244-248, 2013
Cuker A, Gimotty PA, Crowther MA, Warkentin TE: Predictive value of the 4Ts scoring system for heparin-induced thromboctopenia: a systematic review and meta-analysis. Blood 120: 4160-4167, 2012
Sachais BS, Litvinov RI, Yarovoi SV, Rauova L, Hinds JL, Rux AH, Arepally GM, Poncz M, Cuker A, Weisel JW, Cines DB: Dynamic antibody binding properties in the pathogenesis of HIT. Blood 120: 1137-1142, 2012.
Martinez M, Cuker A, Mills A, Lightfoot R, Fan Y, Tang W, Hazen SL, Ischiropoulos H: Nitrated fibrinogen is a biomarker of oxidative stress in venous thromboembolism. Free Radic Biol Med 53: 230-236, 2012.
Cuker A, Cines DB: How I treat heparin-induced thrombocytopenia. Blood 119: 2209-2218, 2012
Lakshmanan S, Cuker A: Comtemporary management of primary immune thrombocytopenia (ITP) in adults. J Thromb Haemost 10: 1988-1998, 2012
back to top
Last updated: 10/16/2016
The Trustees of the University of Pennsylvania